Related references
Note: Only part of the references are listed.Raised calcium and oxidative stress cooperatively promote alpha-synuclein aggregate formation
J. Goodwin et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
α-Synuclein misfolding and Parkinson's disease
Leonid Breydo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Transient Aggregation of Ubiquitinated Proteins Is a Cytosolic Unfolded Protein Response to Inflammation and Endoplasmic Reticulum Stress
Xian-De Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Alpha-synuclein: from secretion to dysfunction and death
O. Marques et al.
CELL DEATH & DISEASE (2012)
Calcium homeostasis in aging neurons
Vassiliki Nikoletopoulou et al.
Frontiers in Genetics (2012)
Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease
David Riascos et al.
ACTA NEUROPATHOLOGICA (2011)
Raised calcium promotes α-synuclein aggregate formation
S. Nath et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Parkin-mediated ubiquitin signalling in aggresome formation and autophagy
Lih-Shen Chin et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
Venu M. Nemani et al.
NEURON (2010)
Biophysics of Parkinson's Disease: Structure and Aggregation of alpha-Synuclein
Vladimir N. Uversky et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2009)
α-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells
Christine L. Kragh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
α-Synuclein modulation of Ca2+signaling in human neuroblastoma (SH-SY5Y) cells
Nishani T. Hettiarachchi et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Formation and development of Lewy pathology: a critical update
Kurt A. Jellinger
JOURNAL OF NEUROLOGY (2009)
Neuroprotective effects of blockers for T-type calcium channels
Norelle C. Wildburger et al.
MOLECULAR NEURODEGENERATION (2009)
α-Synuclein and neuronal cell death
Mark R. Cookson
MOLECULAR NEURODEGENERATION (2009)
Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
Eugene V. Mosharov et al.
NEURON (2009)
Calcium signaling and neurodegenerative diseases
Ilya Bezprozvanny
TRENDS IN MOLECULAR MEDICINE (2009)
Calcium ions in neuronal degeneration
Urszula Wojda et al.
IUBMB LIFE (2008)
Aggregopathy in neurodegenerative diseases: Mechanisms and therapeutic implication
C. P. Dohm et al.
NEURODEGENERATIVE DISEASES (2008)
The impact of the E46K mutation on the properties of α-synuclein in its monomeric and oligomeric states
Ross A. Fredenburg et al.
BIOCHEMISTRY (2007)
Calpain-cleavage of α-synuclein -: Connecting proteolytic processing to disease-linked aggregation
Brian M. Dufty et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
α-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis
Kristin E. Larsen et al.
JOURNAL OF NEUROSCIENCE (2006)
Human neuroblastoma (SH-SY5Y) cell culture and differentiation in 3-D collagen hydrogels for cell-based biosensing
A Desai et al.
BIOSENSORS & BIOELECTRONICS (2006)
Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis.
DL Pountney et al.
NEUROTOXICITY RESEARCH (2005)
Transient increases in extracellular K+ produce two pharmacological distinct cytosolic Ca2+ transients
A Corrales et al.
BRAIN RESEARCH (2005)
Calcium(II) selectively induces α-synuclein annular oligomers via interaction with the C-terminal domain
R Lowe et al.
PROTEIN SCIENCE (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
A structural and functional role for 11-mer repeats in α-synuclein and other exchangeable lipid binding proteins
R Bussell et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Modulation and pharmacology of low voltage-activated (T-type) calcium channels
AMR Yunker
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2003)
Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of α-synuclein, a molecular chaperone
SM Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide
J Chemin et al.
EMBO JOURNAL (2001)
Ca2+ binding to α-synuclein regulates ligand binding and oligomerization
MS Nielsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Molecular pharmacology of T-type Ca2+ channels
TN Heady et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2001)
alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons
PJ McLean et al.
NEUROSCIENCE (2001)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Resting potential of excitable neuroblastoma cells in weak magnetic fields
H Sonnier et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
Share Paper
